20th International Congress » Parkinsons's Disease: Clinical Trials I

Date: Thursday, June 23, 2016

Time: 12:00pm-1:30pm

Session Type: Guided Poster Tour

Meeting: 20th International Congress

12:00pm-1:30pm: A double blind investigation of efficacy and safety of incobotulinumtoxinA in Parkinson’s disease tremor- A customized injection approach

S.O. Mittal, R. Rostami, D.G. Machado, D. Richardson, B. Jabbari (Cleveland, OH, USA)

12:00pm-1:30pm: A multi-centre European comparative survey of advanced therapies (infusion and deep brain stimulation) in Parkinson’s disease

A.M. Rizos, P. Martinez-Martin, P. Reddy, M. Silverdale, K. Ashkan, A. Antonini, D. Calandrella, P. Odin, T. Henriksen, N. Bryndum, A. Glad, M.G. Kramberger, Z. Pirtošek, M. Trošt, T. van Laar, R. Katzenschlager, H.S. Dafsari, L. Timmermann, A. Storch, H. Reichmann, K. Ray Chaudhuri, On behalf of EUROPAR, The IPMDS Non-Motor PD Study Group (London, United Kingdom)

12:00pm-1:30pm: Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson’s disease center

S. Patel, X. Garcia, M.E. Mohammad, X.X. Yu, K. Vlastaris, K. O'Donnell, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)

12:00pm-1:30pm: Factors associated with falling in early, treated Parkinson’s disease: The NET-PD LS1 cohort

K.L. Chou, J.J. Elm, C.L. Wielinski, D.K. Simon, M.J. Aminoff, C.W. Chadwick, G.S. Liang, R.A. Hauser, L. Sudarsky, C.C. Umeh, T. Voss, J. Juncos, J.Y. Fang, J.T. Boyd, I. Bodis-Wollner, M. Zoltan, J.C. Morgan, A.M. Wills, S.L. Lee, S.A. Parashos, On behalf of the NINDS NET-PD Investigators (Ann Arbor, MI, USA)

12:00pm-1:30pm: Mobile decision support system for nurse managment of deep brain stimulation

G. Duffley, D. Martinez, J. Krueger, B. Lutz, M.S. Okun, C.R. Butson (Salt Lake City, UT, USA)

12:00pm-1:30pm: Randomised trial comparing dopamine agonist, MAOB inhibitor and COMT inhibitor as adjuvant therapy in later Parkinson’s disease (PD)

C.E. Clarke, S. Patel, N. Ives, C. Rick, A. Gray, C. Jenkinson, E. McIntosh, K. Wheatley, A. Williams, R. Gray (Birmingham, United Kingdom)

12:00pm-1:30pm: Status of NPF-QII after six years: Updates to the dataset

F. Cubillos, E.C. Nelson, T. Simuni, C. Marras, M. Rafferty, T. Davis, P. Schmidt (Miami, FL, USA)

12:00pm-1:30pm: Switching double-blind opicapone, entacapone or placebo to open-label opicapone: Efficacy results of the 1-year extension of study BIPARK I

J. Ferreira, A. Lees, E. Tolosa, W. Poewe, A. Santos, N. Lopes, J.F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

12:00pm-1:30pm: The Parkinson progression marker initiative (PPMI) – Developing a comprehensive longitudinal biomarker dataset

Parkinson Progression Marker Initiative (New Haven, CT, USA)